DOBUTAMINE HIKMA 12.5 mg/ml, concentrate for solution for infusion 10 bottles of 20 ml
Active ingredients: DL-dobutamine hydrochloride, DOBUTAMINE BASE
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Concentrate for solution for infusion10 bottles of 20 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- DOBUTAMINE HIKMA 12,5 mg/ml, solution à diluer pour perfusion
- Pharmaceutical form
- solution à diluer pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 10 flacon(s) en verre de 20 ml
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 3 Mar 2022
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Emergency use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65014229CIP75508258CIP133400955082583Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE DOBUTAMINEsolution | 14,01 mg · 1 ml de solution | SA |
| DOBUTAMINE BASEsolution | 12,5 mg · 1 ml de solution | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.